These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 17181965

  • 1. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD, Pan LY.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [Abstract] [Full Text] [Related]

  • 2. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines.
    Yan XD, Pan LY, Yuan Y, Lang JH, Mao N.
    J Proteome Res; 2007 Feb; 6(2):772-80. PubMed ID: 17269733
    [Abstract] [Full Text] [Related]

  • 3. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
    Dai Z, Yin J, He H, Li W, Hou C, Qian X, Mao N, Pan L.
    Proteomics; 2010 Nov; 10(21):3789-99. PubMed ID: 20957754
    [Abstract] [Full Text] [Related]

  • 4. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD, Li M, Yuan Y, Mao N, Pan LY.
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [Abstract] [Full Text] [Related]

  • 5. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
    Guan X, Li DR, Wang Q, Li L, Ruan HY, Zhang W.
    Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
    [Abstract] [Full Text] [Related]

  • 6. [Expression of nuclear autoantigenic sperm protein in platinum resistance ovarian cancer cell clones].
    Wang HX, Tan Y.
    Zhonghua Yi Xue Za Zhi; 2010 Jan 05; 90(1):61-3. PubMed ID: 20356529
    [Abstract] [Full Text] [Related]

  • 7. [Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].
    Zhang XP, Xiao ZQ, Chen ZC, Li C, Li JL, Yu YH, Ouyang YM, Feng XP, Zhang PF.
    Ai Zheng; 2006 Jan 05; 25(1):22-8. PubMed ID: 16405744
    [Abstract] [Full Text] [Related]

  • 8. A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.
    Le Moguen K, Lincet H, Marcelo P, Lemoisson E, Heutte N, Duval M, Poulain L, Vinh J, Gauduchon P, Baudin B.
    Proteomics; 2007 Nov 05; 7(22):4090-101. PubMed ID: 17994630
    [Abstract] [Full Text] [Related]

  • 9. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H, Liu T, Yang JL, Huang X, Liu B, Song X, Zhao X, Wei YQ.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 27; 87(8):520-5. PubMed ID: 17459200
    [Abstract] [Full Text] [Related]

  • 10. Proteomic analysis for the identification of proteins related to methotrexate resistance.
    Feng YX, Bai J, Zhang CY, Fu SB.
    Yi Chuan Xue Bao; 2006 May 27; 33(5):391-6. PubMed ID: 16722333
    [Abstract] [Full Text] [Related]

  • 11. Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.
    Le Moguen K, Lincet H, Deslandes E, Hubert-Roux M, Lange C, Poulain L, Gauduchon P, Baudin B.
    Proteomics; 2006 Oct 27; 6(19):5183-92. PubMed ID: 16941573
    [Abstract] [Full Text] [Related]

  • 12. Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.
    Aggarwal S, He T, Fitzhugh W, Rosenthal K, Feild B, Heidbrink J, Mesmer D, Ruben SM, Moore PA.
    Gynecol Oncol; 2009 Dec 27; 115(3):430-7. PubMed ID: 19800108
    [Abstract] [Full Text] [Related]

  • 13. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients.
    Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, Ahn WS.
    Gynecol Oncol; 2005 Oct 27; 99(1):26-35. PubMed ID: 16051329
    [Abstract] [Full Text] [Related]

  • 14. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
    Bo Z, Yongping S, Fengchao W, Guoping A, Yongjiang W.
    Proteomics; 2005 Feb 27; 5(2):426-32. PubMed ID: 15700242
    [Abstract] [Full Text] [Related]

  • 15. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
    Tong A, Zhang H, Li Z, Gou L, Wang Z, Wei H, Tang M, Liang S, Chen L, Huang C, Wei Y.
    Cancer Chemother Pharmacol; 2008 Apr 27; 61(5):791-802. PubMed ID: 17593366
    [Abstract] [Full Text] [Related]

  • 16. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells.
    Lee DH, Chung K, Song JA, Kim TH, Kang H, Huh JH, Jung SG, Ko JJ, An HJ.
    J Proteome Res; 2010 Nov 05; 9(11):5668-76. PubMed ID: 20858016
    [Abstract] [Full Text] [Related]

  • 17. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
    Guidi F, Puglia M, Gabbiani C, Landini I, Gamberi T, Fregona D, Cinellu MA, Nobili S, Mini E, Bini L, Modesti PA, Modesti A, Messori L.
    Mol Biosyst; 2012 Apr 05; 8(4):985-93. PubMed ID: 22134777
    [Abstract] [Full Text] [Related]

  • 18. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC, Chou HC, Chen YW, Lee TR, Chan HT, Shen HH, Lee WT, Lin ST, Lu YC, Wu CL, Chan HL.
    J Proteome Res; 2010 Mar 05; 9(3):1302-22. PubMed ID: 20052998
    [Abstract] [Full Text] [Related]

  • 19. [Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines].
    Su D, Xu SH, Gu LH.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep 05; 40(9):619-22. PubMed ID: 16202319
    [Abstract] [Full Text] [Related]

  • 20. Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells.
    Britten RA, Hardy C, Vlahou A, Gregory B, Giri PS, Drake R.
    Oncol Rep; 2005 Nov 05; 14(5):1323-30. PubMed ID: 16211304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.